Jilin Aodong Pharmaceutical Group Co., Ltd.
000623
Classement en actions
#4850
Jilin Aodong Pharmaceutical Group Co., Ltd. operates in China, principally... Jilin Aodong Pharmaceutical Group Co., Ltd. operates in China, principally focusing on the production and distribution of a broad spectrum of pharmaceutical goods. Its product line encompasses various drug forms like oral liquids, injections, capsules, granules, pills, and tablets, as well as traditional Chinese herbal medicines, powders, syrups, and spirits. The company also produces specialized medicinal products, including enzymes, biochemical drugs, and plant-based chemical medicines. In addition to its core pharmaceutical activities, Jilin Aodong diversifies its operations across several other sectors. These include highway construction and toll management, animal husbandry, the creation of specialty chemicals, and the provision of heat and water. The company further engages in the wholesale, retail, and distribution of medicines, packaging design and printing, the manufacturing of medicinal packaging materials, and delivers information consulting and advertising design solutions. Founded in 1957, its corporate headquarters are situated in Dunhua, China.
Prix de l'action
$2.55
Capitalisation boursière
$3.05B
Changement (1 jour)
3.33%
Changement (1 an)
-11.84%
Pays
CN
Échange Jilin Aodong Pharmaceutical Group Co., Ltd. (000623)
Catégorie
Healthcare
Ratio P/S pour Jilin Aodong Pharmaceutical Group Co., Ltd. (000623)
Ratio P/S au October 2026 TTM : 9.16
Selon les derniers rapports financiers et le cours de l'action de Jilin Aodong Pharmaceutical Group Co., Ltd., le ratio cours/ventes actuel (TTM) est 9.16. À la fin de 2023, le ratio P/S était de 4.95.
Historique du ratio P/S pour Jilin Aodong Pharmaceutical Group Co., Ltd. de 2000 à 2026
Ratio P/S à la fin de chaque année
| Année | Ratio P/S | Changez |
|---|---|---|
| 2026 (TTM) | 9.16 | 17.55% |
| 2024 | 7.79 | 57.42% |
| 2023 | 4.95 | -16.58% |
| 2022 | 5.93 | -35.08% |
| 2021 | 9.14 | 7.82% |
| 2020 | 8.47 | 36.12% |
| 2019 | 6.22 | 23.83% |
| 2018 | 5.03 | -43.06% |
| 2017 | 8.83 | -11.71% |
| 2016 | 10.00 | -15.67% |
| 2015 | 11.86 | -14.55% |
| 2014 | 13.88 | 70.41% |
| 2013 | 8.14 | -22.90% |
| 2012 | 10.56 | -13.66% |
| 2011 | 12.23 | -30.20% |
| 2010 | 17.52 | -36.38% |
| 2009 | 27.55 | 138.21% |
| 2008 | 11.56 | -74.15% |
| 2007 | 44.73 | 263.35% |
| 2006 | 12.31 | 492.21% |
| 2005 | 2.08 | 6.97% |
| 2004 | 1.94 | -2.21% |
| 2003 | 1.99 | -38.79% |
| 2002 | 3.25 | -45.50% |
| 2001 | 5.96 | -42.80% |
| 2000 | 10.41 | 0.00% |
Ratio P/S pour des entreprises similaires ou concurrentes
| Entreprise | Ratio P/S | Différence de Ratio P/S | Pays |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 7.06 | -22.92% |
IN
|
